News Implants could transform CAR-T therapy into one-day procedur... CAR-T therapies have revolutionised the treatment of some blood cancers, but are costly as well as time- and resource-intensive.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.